G. Hartung
Oncology Center
III, Medical University Clinic Mannheim
Germany
Name/email consistency: high
- Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society. Hartung, G., Stehle, G., Sinn, H., Wunder, A., Schrenk, H.H., Heeger, S., Kränzle, M., Edler, L., Frei, E., Fiebig, H.H., Heene, D.L., Maier-Borst, W., Queisser, W. Clin. Cancer Res. (1999)